EBVALLO Trademark

Trademark Overview

On Tuesday, July 5, 2022, a trademark application was filed for EBVALLO with the United States Patent and Trademark Office. The USPTO has given the EBVALLO trademark a serial number of 97489766. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, January 28, 2025. This trademark is owned by Atara Biotherapeutics, Inc.. The EBVALLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, including, cancer, virus-associated disease and autoimmune disease, including multiple sclerosis, systemic lupus erythematosus and diabetes
ebvallo

General Information

Serial Number97489766
Word MarkEBVALLO
Filing DateTuesday, July 5, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements

Goods and ServicesPharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, including, cancer, virus-associated disease and autoimmune disease, including multiple sclerosis, systemic lupus erythematosus and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAtara Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320
Party NameAtara Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, July 8, 2022NEW APPLICATION ENTERED
Monday, July 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 1, 2023SOU EXTENSION 1 FILED
Tuesday, August 1, 2023SOU EXTENSION 1 GRANTED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 7, 2024SOU EXTENSION 2 FILED
Wednesday, February 7, 2024SOU EXTENSION 2 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU EXTENSION 3 FILED
Monday, August 5, 2024SOU EXTENSION 3 GRANTED
Monday, January 27, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2025SOU EXTENSION 4 FILED
Tuesday, January 28, 2025SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 10, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

ebvallo including disease multiple autoimmune sclerosis systemic diabetes erythematosus lupus associated